Related Experiment Videos

Practice and malpractice--the other side of the coin--an attorney's viewpoint

A L Cohn, S Brook

Medical Trial Technique Quarterly

|January 1, 1974

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Biomarker analysis beyond angiogenesis: RAS/RAF mutation status, tumour sidedness, and second-line ramucirumab efficacy in patients with metastatic colorectal carcinoma from RAISE-a global phase III study.

Annals of oncology : official journal of the European Society for Medical Oncology·2018

Analysis of angiogenesis biomarkers for ramucirumab efficacy in patients with metastatic colorectal cancer from RAISE, a global, randomized, double-blind, phase III study.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Cabozantinib in hepatocellular carcinoma: results of a phase 2 placebo-controlled randomized discontinuation study.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Ramucirumab combined with FOLFOX as front-line therapy for advanced esophageal, gastroesophageal junction, or gastric adenocarcinoma: a randomized, double-blind, multicenter Phase II trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2016

Safety and effectiveness of bevacizumab treatment for metastatic colorectal cancer: final results from the Avastin(®) Registry - Investigation of Effectiveness and Safety (ARIES) observational cohort study.

Clinical oncology (Royal College of Radiologists (Great Britain))·2014

A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2013

See all related articles